Drug recall · May 18, 2022
Xanax XR recall
Why: Failed Dissolution Specifications: low out of specification results for dissolution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Fizer Inc, NY, NY 10017, NDC 0009-0068-07.
- Lots / codes
Lot #: DX7983, exp. date 02/28/2023
- Quantity
- 110 bottles
- Company
- Viatris Inc, Canonsburg, PA
- Distribution
- Product was distributed nationwide in the USA
- Initiated
- April 28, 2022 · Voluntary: Firm initiated
- Classified
- May 6, 2022
- Reported
- May 18, 2022
- Ended
- July 13, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Alprazolam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.